Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
89 hedge funds and large institutions have $98.6M invested in Enzo Biochem, Inc. in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 10 closing their positions.
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
47% more capital invested
Capital invested by funds: $66.9M → $98.6M (+$31.7M)
9% more funds holding
Funds holding: 82 → 89 (+7)
9% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 22
0% more call options, than puts
Call options by funds: $415K | Put options by funds: $413K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.37M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.17M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$1.63M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.54M |
| 5 |
Renaissance Technologies
New York
|
+$591K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
-$1.57M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.45M |
| 3 |
Millennium Management
New York
|
-$1.05M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$763K |
| 5 |
LSVM
Lone Star Value Management
Old Greenwich,
Connecticut
|
-$633K |
ENZ Hedge Fund Activity: Q4 2015 in Review
89 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q4 2015, worth a combined $98.6M — up 47% from $66.9M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ENZ positions and 10 closed out — a net gain of 9 holders — while 24 added to existing stakes and 22 trimmed.
The largest buyer was Granahan Investment Management, adding an estimated $3.37M. The largest seller was ClearBridge Investments, cutting an estimated $1.57M.
- 89 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q4 2015, up from 82 in Q3 2015.
- Funds reported $98.6M of Enzo Biochem, Inc. stock for Q4 2015, up 47% quarter-over-quarter.
- 19 funds opened new Enzo Biochem, Inc. positions in Q4 2015 and 10 closed out, a net change of +9 holders.
- The largest Enzo Biochem, Inc. buyer in Q4 2015 was Granahan Investment Management, an estimated $3.37M added.
- The largest Enzo Biochem, Inc. seller in Q4 2015 was ClearBridge Investments, an estimated $1.57M sold.
Based on aggregated 13F filings for Q4 2015.